Literature DB >> 5927631

Clinical immunologic study of malignant disease: response to tumor transplants and transfer of leukocytes.

S H Nadler, G E Moore.   

Abstract

Entities:  

Mesh：

Year:  1966        PMID： 5927631      PMCID： PMC1477263          DOI： 10.1097/00000658-196609000-00011

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  17 in total

1.  AUTOTRANSPLANTATION OF HUMAN CANCER.

Authors:  S H NADLER; G E MOORE
Journal:  JAMA       Date:  1965-01-11       Impact factor: 56.272

2.  IN VITRO CYTOTOXIC EFFECT OF LYMPHOID CELLS FROM MICE IMMUNIZED WITH ALLOGENEIC TISSUE.

Authors:  T VAINIO; O KOSKIMIES; P PERLMANN; H PERLMANN; G KLEIN
Journal:  Nature       Date:  1964-10-31       Impact factor: 49.962

3.  Serum antibodies following homotransplantation of human cancer cells.

Authors:  M AIZAWA; C M SOUTHAM
Journal:  Ann N Y Acad Sci       Date:  1960-05-31       Impact factor: 5.691

4.  Immunity to methylcholanthrene-induced sarcomas.

Authors:  R T PREHN; J M MAIN
Journal:  J Natl Cancer Inst       Date:  1957-06       Impact factor: 13.506

5.  Homotransplantation of human cell lines.

Authors:  A E MOORE; C P RHOADS; C M SOUTHAM
Journal:  Science       Date:  1957-01-25       Impact factor: 47.728

6.  19S antibody production against soluble lipopolysaccharide antigens by individual lymphoid cells in vitro.

Authors:  G Möller
Journal:  Nature       Date:  1965-09-11       Impact factor: 49.962

7.  Culture of human leukemia cells.

Authors:  G E Moore; E Ito; K Ulrich; A A Sandberg
Journal:  Cancer       Date:  1966-05       Impact factor: 6.860

8.  Studies on the mechanism of the cytolytic effect of sensitized lymphocytes.

Authors:  W Rosenau; H D Moon
Journal:  J Immunol       Date:  1966-01       Impact factor: 5.422

9.  QUANTITATIVE STUDIES ON THE BEHAVIOR OF SENSITIZED LYMPHOCYTES IN VITRO. II. INHIBITORY INFLUENCE OF THE IMMUNE SUPPRESSOR, IMURAN, ON THE DESTRUCTIVE REACTION OF SENSITIZED LYMPHOID CELLS AGAINST HOMOLOGOUS TARGET CELLS.

Authors:  D B WILSON
Journal:  J Exp Med       Date:  1965-07-01       Impact factor: 14.307

10.  THE EFFECT OF INTRAPERITONEAL INJECTION OF THORACIC DUCT LYMPHOCYTES FROM NORMAL AND IMMUNIZED RATS IN MICE INOCULATED WITH THE LANDSCHUTZ ASCITES TUMOUR.

Authors:  M F WOODRUFF; M O SYMES; N F ANDERSON
Journal:  Br J Cancer       Date:  1963-09       Impact factor: 7.640
View more
  17 in total

Review 1.  Clinical applications of the continuous flow blood separator machine.

Authors:  C J Oon; J R Hobbs
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

Review 2.  Immunotherapy of human cancers.

Authors:  J R Hobbs
Journal:  BMJ       Date:  1989-11-11

Review 3.  [The immunology of malignant melanoma (author's transl)].

Authors:  G Schieferstein
Journal:  Klin Wochenschr       Date:  1978-03-15

Review 4.  The role of immunology in human cancer research.

Authors:  P Gold
Journal:  Can Med Assoc J       Date:  1970-11-07       Impact factor: 8.262

5.  Human resistance to tumours.

Authors:  G H Fairley
Journal:  Proc R Soc Med       Date:  1967-11-01

6.  Immunotherapy of cancer.

Authors: 
Journal:  Can Med Assoc J       Date:  1968-03-16       Impact factor: 8.262

7.  Immunologic response in patients with disseminated cancer.

Authors:  L J Humphrey; P M Lincoln; W O Griffen
Journal:  Ann Surg       Date:  1968-09       Impact factor: 12.969

8.  Cancer immunity--hypothesis and clinical trial of lymphocytotherapy for malignant diseases.

Authors:  G E Moore; R E Gerner
Journal:  Ann Surg       Date:  1970-10       Impact factor: 12.969

9.  Immunity to malignant disease in man.

Authors:  G H Fairley
Journal:  Br Med J       Date:  1969-05-24

10.  Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy.

Authors:  D L Morton; F R Eilber; W L Joseph; W C Wood; E Trahan; A S Ketcham
Journal:  Ann Surg       Date:  1970-10       Impact factor: 12.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.